The goals of this CME are to describe strategies to eliminate delays in diagnosis of multiple myeloma, outline the latest research relating to multiple myeloma disparities of care and to recognize and refer primary care patients to oncologists who will be able to offer novel targeted therapies in the frontline and relapsed multiple myeloma settings considerate of patient- and disease-related factors and clinical trial availability. In order to provide a comprehensive approach to the goals of this CME, we’ve invited experts from WCM, NYP-Brooklyn Methodist Hospital, Rutgers Cancer Institute and Kings County Hospital Center to serve as presenters and panelists.